Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06758011 · ClinicalTrials.gov registry record · NA
ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 2,400
- Enrollment target
NCT06758011 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 2,400 participants.
The verdict
NCT06758011, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,400 participants
- Enrollment target
Study Summary
This study aims to determine the feasibility of using the ivWatch (registered trademark) device to determine if there is an infiltration at the site of a peripheral intravenous (PIV) catheter. An infiltration is when the IV fluid leaks out of a vein and into the surrounding tissue. If medication starts leaking outside the vein, it can cause damage to the surrounding tissue. Using the ivWatch device may identify leaking fluid before the nurse is able to visually observe the signs or symptoms of the leaking fluid.
Interventions
- DEVICE ivWatch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,400 participants |
| Start Date | 2023-05-17 |
| Est. Completion | 2026-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06758011
The ClinicalTrials.gov registry entry for NCT06758011 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ivWatch is the first listed.
NCT06758011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06758011 about?
NCT06758011 is a clinical study titled "ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting". This study aims to determine the feasibility of using the ivWatch (registered trademark) device to determine if there is an infiltration at the site of a peripheral intravenous (PIV) catheter. An infiltration is when the IV fluid leaks out of a vein and into the surrounding tissue. If medication sta...
What is the current status of trial NCT06758011?
This trial is currently completed. It is a NA study. The enrollment target is 2,400 participants. The study started on 2023-05-17. Estimated completion is 2026-01-26.
What interventions are being tested in trial NCT06758011?
The interventions under investigation include: ivWatch (DEVICE).
Who is sponsoring clinical trial NCT06758011?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.